We build leadership teams for breakthrough companies. Take a look at some of our work. contact us to learn more.

Acucela

Acucela is a clinical-stage biotech company that specializes in discovering and developing novel drugs to treat and slow the progression of sight-threatening ophthalmic diseases.

Positions
Member, Board of Directors
CFO

Alimera Sciences

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals.

Position
Member, Board of Directors

Allergan (Acquired by Actavis)

Allergan is a multi-specialty health care company with an emphasis in eye care, aesthetics, and neurology. (Acquired by Actavis)

Positions
VP Neurology
Sr. Director Clinical Development - Neuorology
Sr. Director Clinical Affairs - Retina
Sr. Medical Director

Angion

Angion is a late-stage biopharmaceutical company focused on
the discovery, development, and commercialization of novel
small molecule therapeutics to address acute organ injuries and
fibrotic diseases.

Position
VP Program Management, Alliance Management & Quality Assurances

Assertio Therapeutics

Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the core areas of neurology, orphan and specialty medicines.

Positions
VP Controller
Director Access & Specialty Pharma Marketing

Cascadian Therapeutics

Cascadian Therapeutics is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. (Acquired by Seattle Genetics)

Position
Sr. VP Regulatory, Quality

Confluence Life Sciences

Confluence Life Sciences is a technology-based company focusing on rational drug design to identify proprietary, mechanistically novel drugs.

Position
Executive Chairman, Board of Directors

Graybug Vision

Graybug Vision is developing novel products for the treatment of people with ocular diseases. The Company’s proprietary injectable products are designed to enable less frequent administration and to reduce the burden of treatment for patients with ocular diseases.

Position
VP Clinical Operations

Immusoft

Immusoft's mission is to treat diseases using its breakthrough technology platform called Immune System Programming (ISP™).

Position
CSO

Invenra

Invenra is focused on discovering the next generation of best-in-class biologics, with an emphasis on antibodies and their derivatives.

Positions
Head of Innovation
VP Corporate Development
Group Leader

Kalytera Therapeutics

Kalytera is advancing a portfolio of non-psychoactive cannabinoid and endocannabinoid-like compounds to address important unmet market needs. Kalytera’s drug candidates are cannabinoid and endocannabinoid-like compounds that strive to improve upon first-generation cannabis products and their analogues by increasing drug specificity while simultaneously reducing or eliminating unwanted side effects.

Position
President, COO, & CFO

Kedalion Therapeutics

Kedalion Therapeutics is a clinical-stage biotechnology company whose mission is to bring to market transformative topical ophthalmic therapies for new and existing indications.

Position
President & CEO

Med-Pharmex

Med-Pharmex manufactures quality generic human and veterinary drug products.

Position
VP Operations

Medicines360

Medicines360 is a nonprofit global women’s health pharmaceutical company with a mission to remove cost as a barrier to health by developing and providing affordable Women’s Health products.

Position
VP Marketing

Millendo Therapeutics

Millendo Therapeutics is focused on developing a broad portfolio of first-in-class, disease-modifying treatments for endocrine diseases caused by hormone dysregulation.

Position
Sr. VP Regulatory

RubrYc Therapeutics

Rubryc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with un-precedented epitope selectivity.

Position
CSO

Santen

Santen specializes in ophthalmic and anti-rheumatic pharmaceuticals.

Position
VP Finance (Promoted to Global CFO)

Sirenas

Sirenas is a company with a validated drug development platform designed to bring unparalleled chemical diversity to high-value therapeutic areas. The company currently specializes in the discovery and development of differentiated payloads for antibody drug conjugates and of new chemical entities in immuno-oncology.

Position
Executive Chair

TearClear

TearClear is an emerging ophthalmic pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface.

Position
Chief Scientific & Innovation Officer

Tricida

Tricida is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD.

Positions
VP Head, Medical Affairs
VP Human Resources
Sr. Director Project Management - CMC
Sr. Director Quality

Vascular Therapies

Vascular Therapies is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring an AV fistula for dialysis.

Position
Sr. VP Regulatory & Quality

Vertex

Vertex Pharmaceuticals uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, and functional genomics -- to speed up the discovery and development of new drugs.

Position
VP Integrated QMS Oversight

Zentalis

Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers.

Positions
CMO
Sr. VP Clinical Development